Closed-loop insulin delivery: current status of diabetes technologies and future prospects
| العنوان: | Closed-loop insulin delivery: current status of diabetes technologies and future prospects |
|---|---|
| المؤلفون: | Hood Thabit, Waseem Majeed |
| المصدر: | Expert Review of Medical Devices. 15:579-590 |
| بيانات النشر: | Informa UK Limited, 2018. |
| سنة النشر: | 2018 |
| مصطلحات موضوعية: | Blood Glucose, Insulin pump, medicine.medical_specialty, medicine.medical_treatment, Biomedical Engineering, Insulin delivery, 030209 endocrinology & metabolism, Biosensing Techniques, Artificial pancreas, 03 medical and health sciences, Drug Delivery Systems, Insulin Infusion Systems, 0302 clinical medicine, Internal medicine, Diabetes mellitus, Pancreatic beta Cells, Diabetes Mellitus, medicine, Humans, Insulin, 030212 general & internal medicine, Type 1 diabetes, business.industry, General Medicine, medicine.disease, Endocrinology, Surgery, business, Closed loop |
| الوصف: | Type 1 diabetes is characterised by destruction of pancreatic beta cells, leading to insulin deficiency and hyperglycaemia. The mainstay of treatment remains lifelong insulin therapy as a sustainable cure has as yet proven elusive. The burden of daily management of type 1 diabetes has contributed to suboptimal outcomes for people living with the condition. Innovative technological approaches have been shown to improve glycaemic and patient-related outcomes.We discuss recent advances in technologies in type 1 diabetes including closed-loop systems, also known as the 'artificial pancreas. Its various components, technical aspects and limitations are reviewed. We also discuss its advent into clinical practice, and other systems in development. Evidence from clinical studies are summarised.The recent approval of a hybrid closed-loop system for clinical use highlights the significant progress made in this field. Results from clinical studies have shown safety and glycaemic benefit, however challenges remain around improving performance and acceptability. More data is required to establish long-term clinical efficacy and cost-effectiveness, to fulfil the expectations of people with type 1 diabetes. |
| تدمد: | 1745-2422 1743-4440 |
| الوصول الحر: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70d3e2196e24382428f326b658ddf4d2Test https://doi.org/10.1080/17434440.2018.1503530Test |
| رقم الانضمام: | edsair.doi.dedup.....70d3e2196e24382428f326b658ddf4d2 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 17452422 17434440 |
|---|